On November 8, 2022, the Brazilian Data Protection Authority (“Authority”) published its 2023-2024 Regulatory Agenda (“Current Agenda”), establishing high-priority topics over the … Brazilian Data Protection Authority publishes its 2023-2024 Regulatory Agenda

On October 19, 2022, the Brazilian House of Representatives approved Bill No. 2.796/2021 that creates a legal framework for the Brazilian gaming … Bill creates Legal Framework for the Electronic Games Industry in Brazil

The Federal Council of Medicine (CFM) published, on 10/14/2022, CFM Resolution No. 2,324/22, which authorizes the use of cannabidiol (CBD) for treatment … CFM updates its Resolution on cannabidiol prescription and use

While registration is not mandatory in Brazil for copyright protection, it is a recommended measure as it may serve as evidence of … Copyright registration in Brazil may now be submitted via online system

ANVISA published, in the Federal Official Gazette, RDC No. 751/2022, which provides and defines, in relation to medical devices, the (i) risk classification rules; (ii) labeling … ANVISA approves new Resolution RDC related to Medical Devices

The new generations of products are the result of the increasing combination of different technologies, leading to a crossing of borders between … Combined products in Brazil – brief comments on Anvisa’s (Brazilian National Health Surveillance Agency) current understanding

The Ministry of Health (MH) sent Brazilian National Health Surveillance Agency (Anvisa) a request for exemption from the sanitary registration, on an … Brazilian National Health Surveillance Agency authorizes exceptional drug and vaccine use against Monkeypox by the Ministry of Health

On August 8th, 2022, during the 12th Extraordinary Public Meeting of DICOL, ANVISA’s Collegiate Board of Directors announced the completion of the toxicological … Brazilian National Health Surveillance Agency (ANVISA) decides to ban Carbendazim

In December 2019, ANVISA started the process of toxicological revaluation of the Active Ingredient (AI) Carbendazim, as signs of toxicity were identified … Carbendazim toxicological revaluation about to be completed by ANVISA

Good news for patent owners in Brazil: the National Congress has upheld the President’s veto n° 48/2021, which prevented those who had their … Compulsory license: patent owners in Brazil are under no obligation to provide know-how and raw materials

Provisional Measure 1,124/22 published this past June 14, 2022, transformed the Brazilian Data Protection Authority into a special nature entity. The Measure is … Provisional Measure Transforms the Brazilian Data Protection Authority into an Independent Entity

At the end of the 12th Ministerial Conference (MC12) of the World Trade Organization (WTO) which took place last Friday (June 17th), an … Latest WTO decision establishes a waiver to patent owner’s rights related to COVID-19 vaccines in developing countries

On 7 June 2022, in the Official Gazette 2683, the Brazilian patent office published a communication regarding the new standard for submission … INPI publishes communication on new sequence listing standard for patent applications in Brazil

On June 1, 2022, the public consultation of the BPTO’s Technical Note CPAPD nº 01/2022 was published in the Federal Official Gazette n° … Brazilian PTOs opens public consultation on inventions related to transgenic plants

The IX Conference on Civil Law took place in May 19 and 20, 2022, which also celebrated the 20th anniversary of the Brazilian … IX Conference on Civil Law and the impacts on Digital Law